15 July 2020: Clinical Research
Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome
Weiwen Liu 1ABC , Huihong Xu 2DE , Xihui Ying 1EFG , Dengke Zhang 1CD , Linqiang Lai 1BC , Linyou Wang 3EF , Jianfei Tu 1CFG* , Jiansong Ji 1BDG*DOI: 10.12659/MSM.923263
Med Sci Monit 2020; 26:e923263
Table 1 The demographic information and clinical characteristics of the patients.
| Characteristic | TACE+RFA | TACE | P | Characteristic | TACE+RFA | TACE | P |
|---|---|---|---|---|---|---|---|
| Age | 0.972 | Child-Pugh class | 0.097 | ||||
| ≤60 | 76 | 47 | A | 114 | 65 | ||
| >60 | 48 | 30 | B | 10 | 12 | ||
| Sex | 0.649 | BCLC stage | |||||
| Male | 112 | 71 | A | 36 | 5 | ||
| Female | 12 | 6 | 6B | 88 | 72 | ||
| HBV infection | 0.326 | AFP level | 0.113 | ||||
| Yes | 107 | 70 | ≤200 U/L | 80 | 41 | ||
| No | 17 | 7 | >200 U/L | 44 | 36 | ||
| Cirrhosis | 0.138 | ALT | 0.646 | ||||
| Yes | 76 | 39 | ≤40 | 70 | 46 | ||
| No | 48 | 38 | >40 | 54 | 31 | ||
| History of surgery | 0.253 | AST level | 0.089 | ||||
| 6Yes | 20 | 8 | ≤40 | 56 | 22 | ||
| No | 104 | 69 | >40 | 68 | 55 | ||
| Tumor size | First TACE | 0.474 | |||||
| ≤5 cm | 70 | 16 | Initial | 50 | 35 | ||
| 5–10 cm | 54 | 61 | Recurrent | 74 | 42 | ||
| No. nodules | 0.027 | Complete ablation | |||||
| One | 73 | 33 | Yes | 92 | 17 | ||
| More | 51 | 44 | No | 32 | 60 |